Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
763.98 | -47.9% | -26.52% | 682,237.16 | 0.69% | 2.63% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
910.00 | -1.78% | 18.6% | 4,053,455.72 | 1.03% | 18.5% |
|
NYSE:TMO
Thermo Fisher Scientific
|
594.80 | -16.78% | -7.46% | 225,479.83 | 0.26% | 14.15% |
|
SWX:ROG
Roche Holding
|
224.60 | 30.46% | 46.37% | 183,894.9 | 4.21% | 0.43% |
|
NYSE:DHR
Danaher
|
259.26 | -16.08% | -4.94% | 186,364.14 | 0.42% | 10.89% |
|
NYSE:ABT
Abbott Laboratories
|
104.01 | 1.76% | 14.42% | 182,261.43 | 2.1% | 9.04% |
|
ENXTPA:SAN
Sanofi
|
91.69 | 14.77% | 33.02% | 115,761.94 | 4.06% | 8.19% |
|
NasdaqGS:LRCX
Lam Research
|
912.54 | -43.83% | -28.5% | 118,162.41 | 0.89% | 13.8% |
|
LSE:GSK
GSK
|
18.10 | 5.36% | 20.88% | 73,812.48 | 3.2% | 0.79% |
|
ASX:CSL
CSL
|
279.58 | 22.63% | 43.58% | 135,272.1 | 1.28% | 7.18% |
|
NYSE:BDX
Becton Dickinson and Co
|
235.00 | 15.14% | 29.24% | 68,480.08 | 1.6% | 2.09% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4205.00 | 0% | 0% | 6,435,766.66 | 4.78% | 0% |
|
NasdaqGS:BIIB
Biogen
|
226.88 | -13.26% | 2.13% | 32,808.8 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
29.22 | 62.97% | 78.88% | 28,863.62 | 0.37% | 1.47% |
|
NYSE:CAH
Cardinal Health Inc
|
97.43 | -24.89% | -14.49% | 23,879.3 | 2.04% | 2.98% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
17.09 | -48.09% | -44.74% | 19,118.97 | 0% | -2.6% |
|
NYSE:BAX
Baxter International Inc
|
35.24 | 81.85% | 109.28% | 18,054.43 | 3.27% | -3.14% |
|
NasdaqGS:HOLX
Hologic
|
75.65 | -20.86% | -14.2% | 17,636.3 | 0% | 12.17% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
79.65 | 142.2% | 221.62% | 15,385.96 | 0% | 32.46% |
|
NYSE:DGX
Quest Diagnostics
|
139.16 | -6.93% | 2.11% | 15,377.3 | 2.13% | 6.66% |
